Global Biomaterials Market Forecast 2022-2030

Global Biomaterials Market Forecast 2022-2030

KEY FINDINGS

The global biomaterials market is estimated to register a CAGR of 12.78% during the forecast period, 2022-2030. Usage of biomaterials in the treatment of bone fixation and plastic surgeries, inventions in the field of biomaterials, the prevalence of cardiovascular diseases in the geriatric population, and government support for research and development initiatives are expected to drive the market growth.

MARKET INSIGHTS

Biomaterials are increasingly found in bio-implant devices, which help treat bone fixation, and in plastic surgeries that are taking place around the world. These materials provide ease in fabrication, flexibility, and biocompatibility. Also, their chemical, mechanical, thermal, and electrical behaviors widen when combined with different materials such as composites.

According to the Australian National Joint Replacement Registry, the total number of joint replacement procedures performed in Australia at the end of 2018 was 1,492,892. Moreover, in 2018, knee replacement increased by 1.2%, and the revision burden was 8.7%. However, the number of procedures is increasing compared to the previous years. The number of joint-related disorder cases increases the scope of replacement therapy, thereby increasing the use of implants in the future.

Additionally, with the increase in the number of elderly people, the demand for plastic surgery, cardiovascular treatment, eye surgery, joint replacement, and other operations has increased exponentially, which has increased the demand for biomaterials required for all the steps of these surgeries.

REGIONAL INSIGHTS

The global biomaterials market growth evaluation includes the geographical analysis of Europe, Asia-Pacific, North America, and Rest of World. Asia-Pacific is expected to grow with the highest growth rate by 2030, owing to the increasing number of plastic surgeries and growing healthcare infrastructure.

COMPETITIVE INSIGHTS

The market comprises several companies, from big corporations to mid-sized domesticated manufacturers, and is a fairly contested space. Also, companies’ strategic decisions, including investments, collaborations, and product launches, contribute to the competitive rivalry in the market, which is estimated to be high throughout the forecast period.

Evonik Industries, BASF, Royal DSM, Covestro AG, Zimmer Biomet Holdings Inc, Mitsubishi Chemical Holdings Corporation, Noble Biomaterials Inc, Dentsply Sirona, etc., are some of the leading companies in the market.

Our report offerings include:
Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation cater to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments